References
-
1) CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: EXP HEMATOLImpactFactor: 2.5DOI: 10.1016/j.exphem.2018.10.011PMID: 30395908 -
2) Crocetin inhibits PDGF-BB-induced proliferation and migration of retinal pigment epithelial cells.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: EUR J PHARMACOLImpactFactor: 4.2DOI: 10.1016/j.ejphar.2018.11.001PMID: 30395849 -
3) Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: BIOMATERIALSImpactFactor: 12.8DOI: 10.1016/j.biomaterials.2019.01.007PMID: 30623789 -
4) Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: CANCER CELL INTImpactFactor: 5.8DOI: 10.1186/s12935-018-0714-9PMID: 30636930 -
5) High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: AM J TRANSL RESImpactFactor: 1.7PMID: 30788000 -
6) Exosomes Derived From Bone Mesenchymal Stem Cells Ameliorate Early Inflammatory Responses Following Traumatic Brain Injury.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: FRONT NEUROSCI-SWITZImpactFactor: 4.3DOI: 10.3389/fnins.2019.00014PMID: 30733666 -
7) circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: MOL CANCERImpactFactor: 37.3DOI: 10.1186/s12943-019-0946-xPMID: 30744636 -
8) Effects of microencapsulated olfactory ensheathing cell transplantation on neuropathic pain and P2X7 receptor expression in the L4-5 spinal cord segment.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: NEUROSCI LETTImpactFactor: 2.5DOI: 10.1016/j.neulet.2019.02.013PMID: 30753909 -
9) Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: EUR J PHARM BIOPHARMImpactFactor: 4.4DOI: 10.1016/j.ejpb.2019.02.013PMID: 30779980 -
10) Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle Arrest.
Product: beta Actin Antibody (#AF7018)Year: 2019Journal: J Clin MedImpactFactor: 3.9DOI: 10.3390/jcm8010044PMID: 30621175 -
11) Blend of organic acids and medium chain fatty acids prevents the inflammatory response and intestinal barrier dysfunction in mice challenged with enterohemorrhagic Escherichia coli O157:H7.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: INT IMMUNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.intimp.2018.03.014PMID: 29555328 -
12) Roles of the MST1-JNK signaling pathway in apoptosis of colorectal cancer cells induced by Taurine.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: Libyan J MedImpactFactor: 1.8DOI: 10.1080/19932820.2018.1500346PMID: 30035680 -
13) Chemerin promotes the viability and migration of human placental microvascular endothelial cells and activates MAPK/AKT signaling .
-
14) Selenium deficiency impaired immune function of the immune organs in young grass carp (Ctenopharyngodon idella).
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: FISH SHELLFISH IMMUNImpactFactor: 4.1DOI: 10.1016/j.fsi.2018.03.024PMID: 29559270 -
15) Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: MAR DRUGSImpactFactor: 5.4DOI: 10.3390/md16030082PMID: 29509717